FTC’s witness admits prosthetic deal hasn’t hurt

On the first day of witness testimony in the Federal Trade Commission’s challenge to a consummated merger of two prosthetics makers, a prosthetic care expert testified that the deal has not affected his clinic’s business, patients or prices.

Get unlimited access to all Global Competition Review content